We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Elevated Interleukin-12/23p40 Indicates Dysfunctional Heart Rate Variability in T2D

By LabMedica International staff writers
Posted on 08 Feb 2022
Print article
Image: Heart rate variability changes with levels of inflammatory serum markers. Left: normal levels of IL-12 and ICAM-1 associated with normal heart rate variability. Right: increased levels of IL-12 and ICAM-1 resulting in decreased heart rate variability. IL-12 is known to associate with arterial stiffness in healthy (Photo courtesy of BMC)
Image: Heart rate variability changes with levels of inflammatory serum markers. Left: normal levels of IL-12 and ICAM-1 associated with normal heart rate variability. Right: increased levels of IL-12 and ICAM-1 resulting in decreased heart rate variability. IL-12 is known to associate with arterial stiffness in healthy (Photo courtesy of BMC)

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in type 2 diabetes (T2D), accounting for approximately 50% of all deaths. Cardiovascular functions, including heart rate, heart contractility, and blood pressure, are regulated by autonomic sympathovagal balance.

Inflammation is an underlying pathogenic component in T2D, along with hyperglycemia, hyperlipidemia, and hypertension, adding to endothelial dysfunction and accelerated atherosclerosis. Systemic inflammation is assessed by serum levels of proinflammatory cytokines such as tumor necrosis factor (TNF)‐α and interleukin (IL) such as IL‐6.

Medical Scientists at the Aalborg University Hospital (Aalborg, Denmark) and their colleagues analyzed serum samples from 100 participants with type 2 diabetes who were recruited consecutively between March 2018 and August 2020. Eligible participants were  ≥ 18 years old, of Northern European descent, with verified T2D for more than 1 year (HbA1c  ≥ 6.5%).

Serum concentrations of angiogenetic markers [basic fibroblast growth factor (bFGF), fms related receptor tyrosine kinase(Flt)-1, phosphatidylinositol-glycan biosynthesis class F protein (PlGF), tyrosine-protein kinase(Tie)-2, vascular endothelial growth factor (VEGF)-C, VEGF-D], cytokines (IL-5, IL-7, IL-12/IL-23p40, IL-15, IL-16, IL-17A, TNF-β, VEGF-A), chemokines [Eotaxin, Eotaxin-3, interferon gamma-induced protein(IP)-10, macrophage-derived chemokine (MCP)-1, MCP-4, monocyte chemoattractant protein (MDC), macrophage inflammatory protein (MIP)-1α, MIP-1β, thymus and activation regulated chemokine (TARC)], proinflammatory cytokines [interferon(IFN)-γ, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α], and vascular injury markers [CRP, ICAM-1, soluble vascular adhesion molecule (VCAM)-1, serum amyloid A (SAA)] were analyzed using V-PLEX Neuroinflammation panel (Meso Scale Diagnostics, Rockville, MD, USA).

The investigators reported that out of 34 examined serum markers, they successfully measured six angiogenetic markers (bFGF, Flt-1, PIGF, Tie-2, VEGF-C, VEGF-D), six chemokines (Eotaxin, IP-10, MCP-1, MDC, MIP-1β, TARC), five cytokines (IL-7, IL-12/IL-23p40, IL-15, IL-16, VEGF-A), five proinflammatory markers (IL-6, IL-8, IL-10, IFN-γ, TNF-α), and four markers of vascular injury (CRP, sICAM1, sVCAM1, SAA), in more than 94% of the samples. Increased serum levels of IL-12/IL-23p40 and intercellular adhesion molecule (ICAM)-1 were associated with diminished heart rate variability measures. After all adjustments, the associations between IL-12/23p40, SDANN and VLF persisted. Additionally, serum levels of vascular endothelial growth factor (VEGF)-C were associated with response to standing.

The authors concluded that had found few but strong associations between neurocardiac function and serum markers, especially IL-12/IL-23p40, suggesting systemic changes in proinflammatory, endothelial, and lymphatic function, impacting overall cardiovascular function. The study was published on January 6 2022 in the journal Cardiovascular Diabetology.

Related Links:
Aalborg University Hospital 
Meso Scale Diagnostics

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.